Advanced Search

Technical Analysis for AUPH - Aurinia Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade C 20.08 1.26% 0.25
AUPH closed up 1.26 percent on Friday, January 17, 2020, on 43 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
8 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Down
Historical AUPH trend table...
Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Multiple of Ten Bullish Other 0.00%
Oversold Stochastic Weakness 0.00%
Hammer Candlestick Bullish 1.26%
NR7 Range Contraction 1.26%
Oversold Stochastic Weakness 1.26%
Stochastic Reached Oversold Weakness 2.19%
Multiple of Ten Bearish Other 2.19%
Older EOD signals for AUPH ...
View Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
AUPH Chart by TradingView
Basic chart:

Profile

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.
Medicine Biopharmaceutical Life Sciences Drugs Autoimmune Diseases Immunosuppressants Peptides Lupus Lupus Nephritis Treatment Of Lupus

Is AUPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jan 13 Oyster Point Pharma up 5% on positive data on lead candidate
Jan 10 Morgan Stanley sees 15% upside in McKesson in premarket analyst action
Jan 2 My Top Stock Pick for 2020 Is a Super Strong Finisher From 2019
Dec 24 The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict
Dec 18 Glaxo's Benlysta successful in lupus nephritis study
Dec 18 The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data
Dec 13 Hedge Funds Have Never Been More Bullish On Aurinia Pharmaceuticals Inc (AUPH)
Dec 13 The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer
Dec 12 Aurinia Closes US$191.7 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common Shares
Dec 10 Why Biotech ETFs are Surging to New Highs
See more AUPH news...

Indicators

Indicator Value
52 Week High 21.93
52 Week Low 3.52
Average Volume 4,058,469
200-Day Moving Average 8.02
50-Day Moving Average 14.18
20-Day Moving Average 20.40
10-Day Moving Average 20.29
Average True Range 1.02
ADX 53.79
+DI 30.22
-DI 16.43
Chandelier Exit (Long, 3 ATRs ) 18.86
Chandelier Exit (Short, 3 ATRs ) 21.52
Upper Bollinger Band 21.65
Lower Bollinger Band 19.15
Percent B (%b) 0.37
BandWidth 12.26
MACD Line 1.39
MACD Signal Line 1.97
MACD Histogram -0.5724
Fundamentals Value
Market Cap 1.68 Billion
Num Shares 83.5 Million
EPS -1.30
Price-to-Earnings (P/E) Ratio -15.45
Price-to-Sales 1112.47
Price-to-Book 2.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.92
Resistance 3 (R3) 20.88 20.57 20.78
Resistance 2 (R2) 20.57 20.35 20.59 20.73
Resistance 1 (R1) 20.32 20.22 20.45 20.36 20.69
Pivot Point 20.01 20.01 20.07 20.03 20.01
Support 1 (S1) 19.76 19.79 19.89 19.80 19.47
Support 2 (S2) 19.45 19.66 19.47 19.43
Support 3 (S3) 19.20 19.45 19.38
Support 4 (S4) 19.24